Loading
SMALLMACHINES
SMALLMACHINES develops microfluidic lab-on-a-chip diagnostic devices with vision-AI analysis: CELLOP for cell analysis, DELISA for digital immunoassay and WHOPE for blood counts. It also offers OEM/ODM chip design and manufacturing and a clinical decision support system. Customers are healthcare providers, emergency rooms, research institutions and biotech partners, and it sells through B2B device and contract-development sales. In 2025 it raised a KRW 3 billion Series A bridge (KRW 1B from Widwin Investment, KRW 2B from Korea Technology Finance Corporation), bringing cumulative funding to about KRW 7 billion. It also completed a GMP production facility in Wonju.
Funding
Every round, secondary, debt facility or acquisition involving SMALLMACHINES that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—